MX2020014095A - Metodos y sistemas para monitorear la salud y enfermedad de organos. - Google Patents

Metodos y sistemas para monitorear la salud y enfermedad de organos.

Info

Publication number
MX2020014095A
MX2020014095A MX2020014095A MX2020014095A MX2020014095A MX 2020014095 A MX2020014095 A MX 2020014095A MX 2020014095 A MX2020014095 A MX 2020014095A MX 2020014095 A MX2020014095 A MX 2020014095A MX 2020014095 A MX2020014095 A MX 2020014095A
Authority
MX
Mexico
Prior art keywords
methods
systems
disease
cfdna
organ health
Prior art date
Application number
MX2020014095A
Other languages
English (en)
Inventor
Yong Li
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Publication of MX2020014095A publication Critical patent/MX2020014095A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan métodos, composiciones y sistemas para monitorear la salud de tejidos y órganos. El método, las composiciones y sistemas proporcionados en la presente extraen señales de número de copia específicas de locus de muestras de ADN libre de células (ADNlc) para identificar perfiles de número de copia de ADNlc específicas de tejido y permiten la cuantificación de fracciones de tejido en las muestras de ADNlc.
MX2020014095A 2019-01-24 2020-01-22 Metodos y sistemas para monitorear la salud y enfermedad de organos. MX2020014095A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962796481P 2019-01-24 2019-01-24
PCT/US2020/014612 WO2020154402A1 (en) 2019-01-24 2020-01-22 Methods and systems for monitoring organ health and disease

Publications (1)

Publication Number Publication Date
MX2020014095A true MX2020014095A (es) 2021-03-09

Family

ID=69726743

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020014095A MX2020014095A (es) 2019-01-24 2020-01-22 Metodos y sistemas para monitorear la salud y enfermedad de organos.

Country Status (12)

Country Link
US (1) US20210310067A1 (es)
EP (1) EP3914731A1 (es)
JP (2) JP2022517456A (es)
KR (1) KR20210119282A (es)
CN (1) CN112424372A (es)
AU (1) AU2020210912A1 (es)
BR (1) BR112020026133A2 (es)
CA (1) CA3104153A1 (es)
IL (1) IL279433A (es)
MX (1) MX2020014095A (es)
SG (1) SG11202012518WA (es)
WO (1) WO2020154402A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116323978A (zh) * 2020-10-20 2023-06-23 深圳华大基因股份有限公司 确定孕妇的孕期状态的方法
WO2022173698A1 (en) * 2021-02-09 2022-08-18 Illumina, Inc. Methods and systems for monitoring organ health and disease
AU2022275540A1 (en) * 2021-05-21 2023-12-14 Zoetis Services Llc Methods and compositions for detecting cancer using fragmentomics
CN113403395B (zh) * 2021-06-03 2023-03-24 南京世和基因生物技术股份有限公司 房水cfDNA的提取方法、试剂盒以及在PVRL临床辅助检查中的应用
EP4373961A1 (en) * 2021-07-23 2024-05-29 Georgetown University Use of genetic and epigenetic markers to detect cell death
KR20240051739A (ko) * 2022-10-13 2024-04-22 인하대학교 산학협력단 cfDNA의 구조 변이 서열 검출을 통한 미세잔존질환 진단 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201505515XA (en) * 2012-01-27 2015-09-29 Univ Leland Stanford Junior Methods for profiling and quantitating cell-free rna
KR20160004265A (ko) * 2013-03-15 2016-01-12 이뮤코 쥐티아이 다이아그노스틱스, 아이엔씨. 무세포 dna를 이용하는 신장 상태의 평가를 위한 방법 및 조성물
US10584331B2 (en) * 2014-07-02 2020-03-10 Dna Chip Research Inc. Method for counting number of nucleic acid molecules
EP3172341A4 (en) * 2014-07-25 2018-03-28 University of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
WO2016070131A1 (en) * 2014-10-30 2016-05-06 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
HUE057821T2 (hu) * 2015-07-23 2022-06-28 Univ Hong Kong Chinese Sejtmentes DNS fragmentációs mintázatának elemzése
WO2018000031A1 (en) * 2016-06-27 2018-01-04 Olivia Newton-John Cancer Research Institute Use of cell free dna as a measure of organ health following transplantation
WO2018009723A1 (en) * 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
EP3497242A4 (en) * 2016-08-10 2020-05-13 Grail, Inc. METHOD FOR ANALYZING NUCLEIC ACID FRAGMENTS
JP7370862B2 (ja) * 2017-03-17 2023-10-30 セクエノム， インコーポレイテッド 遺伝子モザイク症のための方法およびプロセス
WO2018187521A2 (en) * 2017-04-06 2018-10-11 Cornell University Methods of detecting cell-free dna in biological samples

Also Published As

Publication number Publication date
CN112424372A (zh) 2021-02-26
JP2024074960A (ja) 2024-05-31
AU2020210912A1 (en) 2021-01-21
KR20210119282A (ko) 2021-10-05
US20210310067A1 (en) 2021-10-07
IL279433A (en) 2021-01-31
EP3914731A1 (en) 2021-12-01
WO2020154402A1 (en) 2020-07-30
SG11202012518WA (en) 2021-01-28
JP2022517456A (ja) 2022-03-09
BR112020026133A2 (pt) 2021-07-27
CA3104153A1 (en) 2020-07-30

Similar Documents

Publication Publication Date Title
MX2020014095A (es) Metodos y sistemas para monitorear la salud y enfermedad de organos.
MX2021003771A (es) Analisis de analitos multiples usando un ensayo unico.
EP4339288A3 (en) Oligonucleotide probes and uses thereof
MX2021005353A (es) Composiciones, metodos y sistemas para el analisis de la corona proteica y usos de los mismos.
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
WO2015119941A3 (en) Genome fractioning
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
JP2017522908A5 (es)
MA39951A (fr) Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
EP4345168A3 (en) Methods for preparing dna reference material and controls
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2014165267A3 (en) Systems and methods for prenatal genetic analysis
WO2008040027A3 (en) Directed differentiation and maturation of stem cell-derived cardiomyocytes
MX2022002458A (es) Metodo de aislamiento de nucleosomas circulantes.
PH12019500571A1 (en) Anti-pd-1 antibodies
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2005059108A3 (en) Gene expression profiles and methods of use
WO2011087709A3 (en) Eml4-alk translocations in lung cancer
EP2423684A3 (en) Differential expression profiling analysis of cell culture phenotypes and the uses thereof
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
IL292053A (en) Preparations, methods and kits for stabilizing a biological sample and RNA
WO2012145607A3 (en) Specific copy number aberrations as predictors of breast cancer
GB0617116D0 (en) Method of diagnosis